Oakley GP Jr, Adams MJ, Dickinson CM. More folic acid for everyone, now.
J Nutr
. 1996;126:751S - 755S.
Wald NJ, et al. Quantifying the effect of folic acid.
Lancet
. 2001;15;358:2069-73.
Senti FR, Pilch SM. Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES II).
J Nutr.
1985;115:1398 - 1402.
Hoppner K, Lampi B. Bioavailability of folate following ingestion of cholestyramine in the rat.
Int J Vitam Nutr Res.
1991;61:130 - 134.
West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption.
Gut.
1975;16:93 - 98.
Hendel J, Dam M, Gram L, et al. The effects of carbamazepine and valproate on folate metabolism in man.
Acta Neurol Scand.
1984;69:226 - 231.
Reynolds EH, Milner G, Matthews DM, et al. Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism.
QJM.
1966;35:521 - 537.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802 - 817.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother.
1995;29:726 - 735.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc.
1995;95:352 - 356.
Ono H, Sakamoto A, Eguchi T, et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.
Metabolism.
1997;46:959 - 962.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci.
1997;145:109 - 112.
Biale Y, Lewenthal H. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs.
Eur J Obstet Gynecol Reprod Biol.
1984;18:211 - 216.
Baum CL, Selhub J, Rosenberg IH. Antifolate actions of sulfasalazine on intact lymphocytes.
J Lab Clin Med.
1981;97:779 - 784.
Selhub J, Dhar GJ, Rosenberg IH. Inhibition of folate enzymes by sulfasalazine.
J Clin Invest.
1978;61:221 - 224.
Krogh Jensen M, Ekelund S, Svendsen L. Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis.
Scand J Clin Lab Invest.
1996;56:421 - 429.
Baggott JE, Morgan SL, Ha T, et al. Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs.
Biochem J.
1992;282(Pt 1):197 - 202.
Lawrence VA, Loewenstein JE, Eichner ER. Aspirin and folate binding: in vivo and in vitro studies of serum binding and urinary excretion of endogenous folate.
J Lab Clin Med.
1984;103:944 - 948.
Lieberman FL, Bateman JR. Megaloblastic anemia possibly induced by triamterene in patients with alcoholic cirrhosis.
Ann Intern Med.
1968;68:168 - 173.
Mason JB, Zimmerman J, Otradovec CL, et al. Chronic diuretic therapy with moderate doses of triamterene is not associated with folate deficiency.
J Lab Clin Med.
1991;117:365 - 369.
Amos RJ, Amess JA, Hinds CJ, et al. Investigations into the effect of nitrous oxide anaesthesia on folate metabolism in patients receiving intensive care.
Chemioterapia.
1985;4:393 - 399.
Ermens AA, Refsum H, Rupreht J, et al. Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine.
Clin Pharmacol Ther.
1991;49:385 - 393.
Amos RJ, Amess JA, Hinds CJ, et al. Incidence and pathogenesis of acute megaloblastic bone-marrow change in patients receiving intensive care.
Lancet.
1982;2:835 - 838.
Koblin DD, Tomerson BW, Waldman FM, et al. Effect of nitrous oxide on folate and vitamin B
12
metabolism in patients.
Anesth Analg.
1990;71:610 - 617.
Nunn JF, Chanarin I, Tanner AG, et al. Megaloblastic bone marrow changes after repeated nitrous oxide anaesthesia. Reversal with folinic acid.
Br J Anaesth.
1986;58:1469 - 1470.
Kahn SB, Fein SA, Brodsky I. Effects of trimethoprim on folate metabolism in man.
Clin Pharmacol Ther.
1968;9:550 - 560.
Vinnicombe HG, Derrick JP. Dihydropteroate synthase from
Streptococcus pneumoniae:
characterization of substrate binding order and sulfonamide inhibition.
Biochem Biophys Res Commun.
1999;258:752 - 757.
Russell RM, Golner BB, Krasinski SD, et al. Effect of antacid and H
2
receptor antagonists on the intestinal absorption of folic acid.
J Lab Clin Med.
1988;112:458 - 463.
Stumm W, Morgan JJ.
Aquatic Chemistry: An Introduction Emphasizing Chemical Equilibria in Natural Waters.
2nd ed. New York, NY: Wiley; 1981:240.
Deleu D, Louon A, Sivagnanam S, et al. Long-term effects of nitrous oxide anaesthesia on laboratory and clinical parameters in elderly Omani patients: a randomized double-blind study.
J Clin Pharm Ther.
2000;25:271 - 277.
Hernandez-Diaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects.
N Engl J Med
. 2000;343:1608 - 1614.
Steegers-Theunissen RPM, Van Rossum JM, Steegers EAP, et al. Sub-50 oral contraceptives affect folate kinetics.
Gynecol Obstet Invest.
1993;36:230 - 233.
Mooij PNM, Thomas CMG, Doesburg WH, et al. Multivitamin supplementation in oral contraceptive users.
Contraception.
1991;44:277 - 288.
Green TJ, Houghton LA, Donovan U, et al. Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females.
J Am Diet Assoc.
1998;98:49 - 55.
Russell RM, Dutta SK, Oaks EV, et al. Impairment of folic acid absorption by oral pancreatic extracts.
Dig Dis Sci
. 1980;25:369 - 373.
Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects.
JAMA
. 1993;269:1257 - 1261.
Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects.
JAMA.
1989;262:2847 - 2852.
Hernandez-Diaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects.
N Engl J Med
. 2000;343:1608 - 1614.
Rimm EB, Willett WC, Hu FB, et al. Folate and vitamin B
6
from diet and supplements in relation to risk of coronary heart disease among women.
JAMA
. 1998;279:359 - 364.
Moghadasian MH, McManus BM, Frolich JJ. Homocyst(e)ine and coronary artery disease.
Arch Intern Med
. 1997;157:2299 - 2308.
Ubbink JB, van der Merwe A, Vermaak WJH, et al. Hyperhomocysteinemia and the response to vitamin supplementation.
Clin Investig
. 1993;71:993 - 998.
den Heijer M, Brouwer IA, Bos GMJ, et al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers.
Arterioscler Thromb Vasc Biol
. 1998;18:356 - 361.
Ward M, McNulty H, McPartlin J, et al. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.
QJM
. 1997;90:519 - 524.
Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
JAMA
. 1997;277:1775 - 1781.
Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.
Arch Intern Med.
1998;158:862 - 867.
Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels.
Arch Intern Med.
2001;161:695 - 700.
Oakley GP Jr, Adams MJ, Dickinson CM. More folic acid for everyone, now.
J Nutr
. 1996;126:751S - 755S.
Godfrey PSA, Toone BK, Carney MWP, et al. Enhancement of recovery from psychiatric illness by methylfolate.
Lancet
. 1990;336:392 - 395.
Botez MI. Folate deficiency and neurological disorders in adults.
Med Hypotheses
. 1976;2:135 - 140.
Alpert JE, Fava M. Nutrition and depression: the role of folate.
Nutr Rev
. 1997;55:145 - 149.
Passeri M, Cucinotta D, Abate G, et al. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: Results of a double-blind multicenter study.
Aging (Milano)
. 1993;5:63 - 71.
Coppen A, Swade C, Jones SA, et al. Depression and tetrahydrobiopterin: the folate connection.
J Affect Disord
. 1989;16:103 - 107.
Heseker H, Kbler W, Pudel V, et al. Psychological disorders as early symptoms of a mild-to-moderate vitamin deficiency.
Ann N Y Acad Sci
. 1992;669:352 - 357.
Crellin R, Bottiglieri T, Reynolds EH. Folates and psychiatric disorders. Clinical potential.
Drugs
. 1993;45:623 - 636.
Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.
J Affect Disord
. 2000;60:121 - 130.
Butterworth CE Jr. Effect of folate on cervical cancer. Synergism among risk factors.
Ann N Y Acad Sci
. 1992;669:293 - 299.
Kim Y-I, Mason JB. Folate, epithelial dysplasia and colon cancer.
Proc Assoc Am Physicians
. 1995;107:218 - 227.
Heimburger DC. Localized deficiencies of folic acid in aerodigestive tissues.
Ann N Y Acad Sci
. 1992;669:87 - 96.
Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake and the risk of breast cancer.
JAMA.
1999;281:1632 - 1637.
Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ, et al. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers.
Am J Epidemiol.
2001;153:680 - 687.
Heimburger DC. Localized deficiencies of folic acid in aerodigestive tissues.
Ann N Y Acad Sci
. 1992;669:87 - 96.
Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma.
J Natl Cancer Inst;
1993;85:875 - 884.
Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.
Ann Intern Med.
1998;129:517 - 524.
Baron JA, Sandler RS, Haile RW, et al. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas.
J Natl Cancer Inst.
1998;90:57 - 62.
Butterworth CE Jr, Hatch KD, Gore H, et al. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives.
Am J Clin Nutr.
1982;35:73 - 82.
Butterworth CE Jr, Hatch KD, Soong SJ, et al. Oral folic acid supplementation for cervical dysplasia: A clinical intervention trial.
Am J Obstet Gynecol.
1992;166:803 - 809.56.
Snowdon DA, Tully CL, Smith CD, et al. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study.
Am J Clin Nutr.
2000;71:993 - 998.
van Ede AE, Laan RF, Rood MJ, et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
Arthritis Rheum.
2001;44:1515 - 1524.
Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial.
Ann Intern Med.
1994;121:833 - 841.
Griffith SM, Fisher J, Clarke S, et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?
Rheumatology (Oxford).
2000;39:1102 - 1109.
Hunt PG, Rose CD, McIlvain-Simpson G, et al. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study.
J Rheumatol.
1997;24:2230 - 2232.
Duhra P. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis.
J Am Acad Dermatol.
1993;28:466 - 469.
Gori T, Burstein JM, Ahmed S, et al. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study.
Circulation.
2001;104:1119 - 1123.
Oster KA. Evaluation of serum cholesterol reduction and xanthine oxidase inhibition in the treatment of atherosclerosis.
Recent Adv Stud Cardiac Struct Metab
. 1973;3:73 - 80.
Boss GR, Ragsdale RA, Zettner A, et al. Failure of folic acid (pteroylglutamic acid) to affect hyperuricemia
. J Lab Clin Med
. 1980;96:783 - 789.
Flouvier B, Devulder B. Folic acid, xanthine oxidase, and uric acid [letter].
Ann Intern Med.
1978;88:269.
Boss GR, Ragsdale RA, Zettner A, et al. Failure of folic acid (pteroylglutamic acid) to affect hyperuricemia
. J Lab Clin Med
. 1980;96:783 - 789.
O'Keeffe ST. Restless legs syndrome. A review.
Arch Intern Med.
1996;156:243 - 248.
Brattstrom LE, Hultberg BL, Hardebo JE. Folic acid responsive postmenopausal homocysteinemia.
Metabolism.
1985;34:1073 - 1077.
Flynn MA, Irvin W, Krause G. The effect of folate and cobalamin on osteoarthritic hands.
J Am Coll Nutr
. 1994;13:351 - 356.
Kremer JM, Bigaouette J. Nutrient intake of patients with rheumatoid arthritis is deficient in pyridoxine, zinc, copper, and magnesium.
J Rheumatol
. 1996;23:990 - 994.
Montes LF, Diaz ML, Lajous J, et al. Folic acid and vitamin B
12
in vitiligo: a nutritional approach.
Cutis
. 1992;50:39 - 42.
Coppen A, Abou-Saleh MT. Plasma folate and affective morbidity during long-term lithium therapy.
Br J Psychiatry.
1982;141:87 - 89.
Coppen A, Chaudhry S, Swade C. Folic acid enhances lithium prophylaxis.
JAffect Disord.
1986;10:9 - 13.
Callaghan TJ. The effect of folic acid on seborrheic dermatitis.
Cutis.
1967;3:583 - 588.
Juhlin L, Olsson MJ. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure.
Acta Derm Venereol (Stockh)
. 1997;77:460 - 462.
Kim SM, Kim YK, Hann S-K. Serum levels of folic acid and vitamin B12 in Korean patients with vitiligo.
Yonsei Med J
. 1999;40:195 - 198.
Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects.
JAMA
. 1993;269:1257 - 1261.
Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects.
JAMA
. 1989;262:2847 - 2852.
Hernandez-Diaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects.
N Engl J Med
. 2000;343:1608 - 1614.
Rimm EB, Willett WC, Hu FB, et al. Folate and vitamin B
6
from diet and supplements in relation to risk of coronary heart disease among women.
JAMA
. 1998;279:359 - 364.
Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
. JAMA.
1997;277:1775 - 1781.
Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.
Arch Intern Med.
1998;158:862 - 867.
Moghadasian MH, McManus BM, Frohlich JJ. Homocyst(e)ine and coronary artery disease.
Arch Intern Med
. 1997;157:2299 - 2308.
Ubbink JB, van der Merwe A, Vermaak WJH, et al. Hyperhomocysteinemia and the response to vitamin supplementation.
Clin Investig
. 1993;71:993 - 998.
den Heijer M, Brouwer IA, Bos GMJ, et al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers.
Arterioscler Thromb Vasc Biol
. 1998;18:356 - 361.
Ward M, McNulty H, McPartlin J, et al. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.
QJM
. 1997;90:519 - 524.
Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.
Arch Intern Med.
1998;158:862 - 867.
Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels.
Arch Intern Med.
2001;161:695 - 700.
Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels.
Arch Intern Med.
2001;161:695 - 700.
Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.
J Affect Disord
. 2000;60:121 - 130.
van Ede AE, Laan RF, Rood MJ, et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
Arthritis Rheum.
2001;44:1515 - 1524.
Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial.
Ann Intern Med.
1994;121:833 - 841.
Griffith SM, Fisher J, Clarke S, et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?
Rheumatology (Oxford).
2000;39:1102 - 1109.
Hunt PG, Rose CD, McIlvain-Simpson G, et al. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study.
J Rheumatol.
1997;24:2230 - 2232.
Duhra P. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis.
J Am Acad Dermatol.
1993;28:466 - 469.
Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review.
Am J Clin Nutr
. 1989;50:353 - 358.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother.
1995;29:726 - 735.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc.
1995;95:352 - 356.
Ono H, Sakamoto A, Eguchi T, et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.
Metabolism.
1997;46:959 - 962.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci.
1997;145:109 - 112.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802 - 817.
Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B
6
, Folate, Vitamin B
12
, Pantothenic Acid, Biotin, and Choline (1998). Available at www.nap.edu. Accessed October 4, 2001.
Cembrowski GS, Zhang MM, Prosser CI, Higgins T. Folate is not what it is cracked up to be.
Arch Intern Med.
1999;159:2747-2748.
Venn BJ, Mann JI, Williams SM, et al. Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial.
Eur J Clin Nutr.
2002;56:748-754.
Ortiz Z, Shea B, Suarez-Almazor ME, et al. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A meta-analysis of randomized controlled trials.
J Rheumatol.
1998;25:36-43.
Van Ede AE, Laan RF, Blom HJ, et al. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
Rheumatology (Oxford)
. 2002;41(6):658-665.
Morgan SL, Baggott JE, Lee JY, Alarcon GS. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
J Rheumatol.
1998;25:441-446.
Mangoni AA, Sherwood RA, Swift CG, et al. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
J Intern Med
. 2002;252:497 - 503.
Último revisado Septiembre 2003 por EBSCO CAM Medical Review Board
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
Copyright © EBSCO Publishing. All rights reserved.